Mcf Advisors LLC Abb Vie Inc. Transaction History

Mcf Advisors LLC

$1.42 Billion
Q3 2024

A detailed history of Mcf Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 10,508 shares of ABBV stock, worth $1.89 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

10,508

Previous 10,309 1.93%

Holding current value

$1.89 Million

Previous $1.77 Million 17.36%

% of portfolio

0.15%

Previous 0.13%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $32,604 - $39,666	199 Added 1.93%	10,508 $2.08 Million
Q2 2024 Aug 05, 2024	BUY	$154.79 - $180.76 $225,838 - $263,728	1,459 Added 16.49%	10,309 $1.77 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $4,794 - $5,463	-30 Reduced 0.34%	8,850 $1.61 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $1,788 - $2,014	-13 Reduced 0.15%	8,880 $1.38 Million
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $6,278 - $7,268	47 Added 0.53%	8,893 $1.33 Million
Q2 2023 Jul 24, 2023	BUY	$132.51 - $164.9 $125,884 - $156,655	950 Added 12.03%	8,846 $1.19 Million
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $33,260 - $38,304	230 Added 3.0%	7,896 $1.26 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $1,798 - $2,156	13 Added 0.17%	7,666 $1.24 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $1,073 - $1,231	8 Added 0.1%	7,653 $1.03 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $60,828 - $77,332	442 Added 6.14%	7,645 $1.17 Million
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $950,651 - $1.18 Million	7,203 New	7,203 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $814,749 - $1.03 Million	-7,584 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $34,260 - $38,891	322 Added 4.43%	7,584 $818,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $107,629 - $119,905	1,023 Added 16.4%	7,262 $818,000
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $107,721 - $118,588	1,053 Added 20.3%	6,239 $675,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $22,852 - $26,820	266 Added 5.41%	5,186 $454,000
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $8,877 - $11,879	-121 Reduced 2.4%	4,920 $483,000
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $84,582 - $101,691	1,343 Added 36.32%	5,041 $382,000
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $7,949 - $10,161	121 Added 3.38%	3,698 $269,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $30,007 - $35,317	-389 Reduced 9.81%	3,577 $288,000
Q3 2018 Oct 24, 2018	SELL	$88.91 - $98.84 $352,617 - $391,999	-3,966 Reduced 50.0%	3,966 $375,000
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $356,067 - $421,308	3,966 Added 100.0%	7,932 $742,000
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $447 - $491	5 Added 0.13%	3,966 $384,000
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $276,675 - $353,400	3,961	3,961 $352,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account